GC30917
AM-2099
Also known as 4-[2-methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamide
AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1·7 with an IC50 of 0·16 μM for human Nav1·7
ChemicalCAS1443373-17-8MW466.46FormulaC19H13F3N4O3S2
- CAS number
- 1443373-17-8
- Molecular weight
- 466.46
- Formula
- C19H13F3N4O3S2
- Solubility
- DMSO ： ≥ 150 mg/mL (321·57 mM)
- InChIKey
- VSUDRCZPHWUXEW-UHFFFAOYSA-N
- Catalogue number
- GC30917
- Brand
- GLPBIO
Computed properties PubChem CID 86687532 · XLogP 3.9 · TPSA 131 Ų · H-bond donors 1
- XLogP
- 3.9
- TPSA
- 131 Ų
- H-bond donors
- 1
- H-bond acceptors
- 11
- Rotatable bonds
- 5
- Heavy atoms
- 31
SMILES COC1=C(C=CC(=C1)C(F)(F)F)C2=NC=NC3=C2C=CC(=C3)S(=O)(=O)NC4=NC=CS4
Computed descriptors from PubChem (CID 86687532), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il